Harald Halbhuber

Harald Halbhuber

Partner

Harald focuses on complex corporate finance transactions, representing issuers and investment banks in debt and equity offerings, high yield financings, debt restructurings and equity derivatives. 

He also advises clients on critical disclosure and financial reporting matters, an area on which he has authored several publications.

Harald is also an Adjunct Professor at NYU School of Law, where he teaches a course on Capital Markets Transactions.

Experience

Representative matters

  • Placement agent to Lotus Technology Inc. to L Catterton Asia Acquisition Corp. (LCAA) in connection with the business combination between Lotus Tech and LCAA. 
  • Intercontinental Exchange, Inc. in connection with its $13.1 billion merger with Black Knight, Inc.
  • The underwriters in connection with the $143.75 million follow-on offering of common stock by Caribou Biosciences, Inc.
  • Valvoline Inc. on corporate finance matters in connection with the $2.65 billion sale of its Global Products business to Aramco.
  • Ambipar Emergency Response in connection with its $798 million business combination with HPX.
  • The book-running manager in connection with a $120.6 million and $72.3 million follow-on offering of common stock by Tidewater Inc.
  • Accident Fund Insurance Company of America in its offering of $350 million of surplus notes. 
  • The joint book-running managers in connection with the $900 million Sustainability-Linked notes by TELUS Corporation.
  • The underwriters in connection with the $110.4 million initial public offering and $143.8 million follow-on offering of common stock by Y-mAbs Therapeutics, Inc.
  • The underwriters in connection with the $176 million initial public offering of Lucira Health, Inc.
  • Microvast, Inc., in its $3 billion going public and Nasdaq listing through a merger with a SPAC.
  • Bakkt Holdings, LLC, in its $2.1 billion going public and NYSE listing through a merger with a SPAC.
  • Valvoline in its $1 billion modified Dutch auction equity self-tender offer and $535 million offering of senior notes. 
  • CVS Health Corporation on its $4 billion and $2 billion bond offerings and related cash tender offers. 
  • Liberty Global in its $2.5 billion modified Dutch auction equity self-tender offer. 
  • LyondellBasell in its $3 billion modified Dutch auction equity self-tender offer.
  • Genmab in its Nasdaq IPO (at $11 billion, the largest biotech IPO in 20 years by market cap). 
  • The underwriters in connection with the $84 million initial public offering of HOOKIPA Pharma Inc. 
  • The underwriters in connection with the $747.5 million offering of convertible senior notes by Exact Sciences Corporation. 
  • Barclays Capital as dealer manager for the $450 million rights offering of Roadrunner Transportation (one of the largest rights offerings as a percentage of market cap). 
  • The underwriters in connection with the $120 million initial public offering of Axonics Modulation Technologies, Inc. 
  • General Electric in its $4.5 billion aggregate common stock offerings of Baker Hughes.
  • Intercontinental Exchange, Inc. on the financings for its $11 billion acquisition of NYSE Euronext and its $5 billion acquisition of IDC.
  • Liberty Global on its $24 billion acquisition of Virgin Media and its $5 billion acquisition of Cable & Wireless. 
  • Liberty Global on its acquisition of a 3.4% stake in Lions Gate Entertainment and related governance arrangements and equity derivatives transactions.
  • Liberty Global on the creation of its LiLAC shares, the first ever tracking stock issued by a UK public company. 
  • Financing providers in connection with financing commitments and bond-takeouts for proposed acquisitions, both by financial sponsors and strategic buyers.
  • B/E Aerospace on the $2.5 billion spin-off of KLX and the related financing transactions. 

Published Work

  • Halbhuber, H. (2020) “Forced Debt for Equity Exchange Outside Bankruptcy Impairs Bondholder Payment Rights”, Twenty Eagle
  • Halbhuber, H. (2017) “Debt Restructuring and the Trust Indenture Act, 25”, American Bankruptcy Institute Law Review 
  • Halbhuber, H. (2016) “A Financial Statement Guide Through the Seasons”, Insights—The Corporate and Securities Law Advisor
  • Halbhuber, H. (2016) “Financial Statements Triggered by Acquisitions—What You Need”, Insights—The Corporate and Securities Law Advisor
  • Halbhuber, H. (2016) “Financial Statements Triggered by Acquisitions—When You Need Them”, Insights—The Corporate and Securities Law Advisor
  • Halbhuber, H. (2001) “National Doctrinal Structures and European Company Law, 38”, Common Market Law Review 1385
  • Halbhuber, H. (2001) “Limited Company statt GmbH”, Baden-Baden: Nomos (in German)

Leadership Positions And Professional Affiliations

  • Research Fellow, NYU School of Law’s Institute for Corporate Governance & Finance, 2021
  • Visiting Scholar, Columbia Law School, 2010
  • Adjunct Professor, NYU School of Law

Qualifications

Admissions

New York, 1999

Academic

LL.M., Master of Laws, Harvard University, 1997
J.D., University of Vienna
S.J.D., summa cum laude, University of Vienna

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.